|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
|
|---|---|---|---|---|---|---|---|---|---|
| Current Assets | |||||||||
| Cash | |||||||||
| Receivables | |||||||||
| Total Current Assets | |||||||||
| Total Assets | |||||||||
| Liabilities and Stockholders Equity | |||||||||
| Accrued expenses | |||||||||
| Accounts Payables | |||||||||
| Related Party Payables | |||||||||
| Convertible Note Payable | |||||||||
| Total Current Liabilities | |||||||||
| Long term Note Payable | |||||||||
| Convertible Note payable | |||||||||
| Total Liabilities | |||||||||
| Stockholders’ Equity | |||||||||
| Common Stock, $0.001 par value, 500,000,000 shares authorized, 109,500,000 and 109,500,000 shares issued and outstanding, respectively | |||||||||
| Additional Paid in capital | |||||||||
| Accumulated Deficit | |||||||||
| Total Stockholders’ Deficit | |||||||||
| Total Liabilities and Stockholders’ Deficit |
Loading...
